🔗 Visit the ClinicalTrials.gov page for NCT01892293
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Adoptive immunotherapy for cancer or viruses. | Annu Rev Immunol | 2014 | 1.61 |
| 2 | Engineered T cells: the promise and challenges of cancer immunotherapy. | Nat Rev Cancer | 2016 | 1.51 |
| 3 | Trial Watch: Adoptive cell transfer for anticancer immunotherapy. | Oncoimmunology | 2014 | 0.96 |
| 4 | Engineered T cells for cancer therapy. | Cancer Immunol Immunother | 2014 | 0.95 |
| 5 | Synthetic biology in cell-based cancer immunotherapy. | Trends Biotechnol | 2015 | 0.84 |
| 6 | Development of Novel Immunotherapies for Multiple Myeloma. | Int J Mol Sci | 2016 | 0.82 |
| 7 | Targeting CD8+ T-cell tolerance for cancer immunotherapy. | Immunotherapy | 2014 | 0.81 |